OBJECTIVES: To briefly inform on the conclusions from a conference on the next 10 years in
the management of peripheral artery disease (PAD). DESIGN OF THE CONFERENCE …

Aims: Data on long-term healthcare costs of patients with peripheral artery disease (PAD) is
limited, and the aim of this study was to investigate healthcare costs for PAD patients at a …

Objective Long-term progression of peripheral arterial disease (PAD) as initial manifestation
of atherosclerotic arterial disease is not well described. Cardiovascular (CV) risk was …

Peripheral artery disease (PAD) is associated with substantial morbidity, including a high
risk of cardiovascular and limb events and death. A growing body of evidence has …

Peripheral arterial occlusive disease (PAD) is a highly prevalent atherosclerotic syndrome
associated with significant morbidity and mortality. It is defined by atherosclerotic obstruction …

Background and aims It is unclear whether improvements in the detection/treatment of
peripheral artery disease (PAD) affect overall survival and morbidity. We undertook a …

Peripheral arterial disease (PAD) now affects approximately 20% of adults older than 55
years to an estimated total of 27 million people in the Western World. The aim of this paper is …

Objective The objective of this study was to describe the epidemiology, clinical features,
outcomes, and predictors of mortality in veterans with peripheral artery disease (PAD) …

Peripheral arterial disease (PAD) is associated with a high morbidity and mortality, largely
from coronary and cerebrovascular disease, which often overshadows the PAD itself. Best …

Background Patients with peripheral artery disease (PAD) are at very high risk of future
cardiovascular (CV) events. Strict lipid-lowering therapy is recommended. However, data on …